Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer

NCT00431054 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Perifosine
DRUG: Docetaxel

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]